CD44v6‐peptide functionalized nanoparticles selectively bind to metastatic cancer cells
CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to CD44v6 positive tumor cells with highly efficient anticancer and antimetastatic properties. The reported modular synthesis and facile preparation makes this system highly potent for dev...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Advanced science
Year: 2016, Volume: 4, Issue: 1 |
| ISSN: | 2198-3844 |
| DOI: | 10.1002/advs.201600202 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1002/advs.201600202 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/advs.201600202 
|
| Author Notes: | Linxian Li, Mark Schmitt, Alexandra Matzke‐Ogi, Parvesh Wadhwani, Veronique Orian‐Rousseau, and Pavel A. Levkin |
| Summary: | CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to CD44v6 positive tumor cells with highly efficient anticancer and antimetastatic properties. The reported modular synthesis and facile preparation makes this system highly potent for developing novel multifunctional nanocarriers for therapeutic and/or diagnostic anticancer applications. |
|---|---|
| Item Description: | First published: 20 December 2016 Gesehen am 13.09.2018 |
| Physical Description: | Online Resource |
| ISSN: | 2198-3844 |
| DOI: | 10.1002/advs.201600202 |